Recently Viewed

News Announcement

Goldline Pharmaceutical: Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

01-Sep-2026 Follow Value Research Online on Google download pdfDownload PDF Goldline Pharmaceutical

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Amol Laxmikant Mujumdar

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.

Mutual Fund Insight turns 24! 🎉 Get 2 FREE anniversary guides: The Right SIP + The Big Funds